Internal Server Error

About Breakout Labs

Breakout Labs is a venture capital firm founded in 2011. It is primarily based out of San Francisco, United States. As of Jul 2022, Breakout Labs has invested in 44 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of NAPIGEN Overall, Breakout Labs portfolio has seen 2 IPOs and 3 acquisitions including key companies like Quince Therapeutics, FlightWave Aerospace and Azitra. A lot of funds co-invest with Breakout Labs, with names like Horizons Ventures sharing a substantial percentage of its portfolio. Breakout Labs has team of 1 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Grant (prize money) & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns

Breakout Labs' List of Top Investments

Breakout Labs has a portfolio of 44 companies. Their most notable investments are in Nuclease Probe Technologies and Azitra.Their portfolio spans across United States and Canada. They have invested in Life Sciences, High Tech, Enterprise Applications and 12 other sectors, across stages such as Seed, Grant (prize money)  and 2 more. Here is the list of top investments by Breakout Labs:
Developer of carbon transformation technology producing fuels and feedstock products. The company's technology transforms carbon dioxide, water, and renewable electricity into hydrocarbons. These hydrocarbons are drop-in replacements for conventional petroleum-based materials and ingredients. The resulting products have zero fossil fuels, zero emissions, and no trade-offs in quality.

Key facts about Twelve

Developer of bio-fabricated materials for fashion, interiors, and automotive industries. The company focuses on creating animal-free leather alternatives using plant-based proteins, biopolymers, and recycled rubber. These materials are engineered to replicate the look and feel of collagen found in leather. The company's materials are versatile, functional, scalable, and adaptable to existing manufacturing processes.

Key facts about Modern Meadow

CytoVale is focussed on developing biomarkers for the early detection of sepsis, an infectious reaction that can lead to lung, kidney and liver failure. Its technology is based on the mechanical properties of individual cells (mechanomics). The instrument uses microfluidics to route and physically probe individual cells and claims to have the capacity to measure over 10 biophysical cell markers at rates above 2k cells per second, providing a high-throughput detection of the disease.

Key facts about CytoVale

AI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics. It offers SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence.

Key facts about Envisagenics

  • Founded Year: 2014
  • Location: Long Island City (United States)
  • Stage: Series B
  • Total Funding till date: $46.8M
  • Employee Count: 33 as on Aug 31, 2026
  • Investors: Bristol-Myers Squibb, ESD and 17 Others
  • Latest Funding Round: Series B, Jun 05, 2024, $*****
  • Highlight: Editors' Pick
Provider of engineered microbes and biosynthetic pathways for industrial chemicals. The company is re-engineering the microbe and is designing a new biosynthetic pathway to eliminate/reduce the carbon loss in the biological conversion of sugars and other bio-based feedstocks. It claims that the chemicals are produced in the manufacturing of consumer products.

Key facts about Zymochem

  • Founded Year: 2014
  • Location: Berkeley (United States)
  • Stage: Series A
  • Total Funding till date: $25.4M
  • Employee Count: 48 as on Aug 31, 2026
  • Investors: InCred, Toyota Ventures and 15 Others
  • Latest Funding Round: Grant (prize money), Jun 04, 2025, $*****
  • Highlight: Editors' Pick

Breakout Labs' Investments by Stage

Breakout Labs has made 21 investments in Seed stage with an average round size of $1.12M, 10 investments in Grant (prize money) stage with an average round size of $302K, 1 investment in PE stage and 1 investment in Series A stage with an average round size of $10M.
Here are Breakout Labs' investments by stage:
Stage of entry
No. of Investments
Seed
21
Grant (prize money)
10
PE
1
Series A
1
Breakdown of Breakout Labs' investments by stage of entrySeed (21)Grant (prize money) (10)
Note: We have considered here, only first round of investments

Breakout Labs' Investments by Sector

Breakout Labs has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, Chemicals and Materials Tech and Enterprise Applications. Notably, it has invested in 41 Tech companies, 36 Enterprise (B2B) companies, 16 Tech hardware companies and at least 10 companies focusing on Software.
Here are Breakout Labs' investments by sector:
Sector
No. of Investments
Life Sciences
18
High Tech
17
Sustainability Tech
7
Chemicals and Materials Tech
6
Enterprise Applications
5
Others
27
Breakdown of Breakout Labs' investments by sectorsLife Sciences (18)High Tech (17)
Note: We have considered here, only first round of investments

Breakout Labs' Investments by Geography

Breakout Labs has made most investments in United States (33).

Breakout Labs' recent investments

Breakout Labs has not made any investment in 2026 so far.
Here are the most recent investments by Breakout Labs:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jul 12, 2022
United States
Seed
6809
Mar 05, 2019
United States
Seed
6514
-
Nov 27, 2018
United States
Seed
8183
-
Oct 27, 2018
United States
Seed
3152
-
Sep 25, 2018
United States
Seed
2268

IPOs and Publicly Listed companies in Breakout Labs' Portfolio

2 of Breakout Labs' portfolio companies have become public. Azitra got listed on the American Stock Exchange (NYSEAMERICAN), in Jun 2023 at marketcap of $60.4M and Quince Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $442M.
Here are Breakout Labs' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 16, 2023
Oct 11, 2016
Seed
6949
May 09, 2019
Jun 11, 2014
Seed
4982

Acquired companies in Breakout Labs' Portfolio

3 companies from Breakout Labs' portfolio have been acquired. The most recent acquisition was FlightWave Aerospace in Sep 2024 by Red Cat for $*****.
Here are Breakout Labs' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 05, 2024
Aug 15, 2017
Seed
7652
Nov 15, 2022
Sep 26, 2017
Seed
7972
Dec 02, 2013
Apr 17, 2013
Grant (prize money)
3295

Team profile of Breakout Labs

Breakout Labs has a team of 1 member located in United States. Breakout Labs' team sits on the board of 1 company.

Co-investors of Breakout Labs

Over the past 14 years, 175 investors have co-invested in Breakout Labs's portfolio companies. This includes funds and angels.

  • Invested before Breakout Labs: National Science Foundation, HHS and 12 others have invested in rounds before Breakout Labs. There are 6 companies where National Science Foundation has invested before Breakout Labs and 6 companies where HHS has invested before Breakout Labs.
  • Top Co-investors of Breakout Labs: 13 investors entered a company along with Breakout Labs. These include investors like Horizons Ventures (1 company).
  • Invested after Breakout Labs: A total of 148 investors have invested in Breakout Labs's portfolio after their investments. Top Investors include America’s Seed Fund (8 companies), Breakout Ventures (7 companies) and HHS (5 companies).

Recent News related to Breakout Labs

•
View all news related to Breakout Labs

FAQs about Breakout Labs

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford